Sodium butyrate does not decrease the evolution of precancerous lesions in rats

Acta Cirurgica Brasileira

Volumn 25, Issue 6, 2010, Pages 507-512

  Silva, Fernanda Guimarães Drummond ^a   Penido, Luisa Costa Penna ^a   Valente, Flávia Xavier ^a   Mendes, Maria Carolina Santos ^b   Rosa, Damiana Diniz ^a   Glória, Maria Beatriz Abreu ^c   Peluzio, Maria Do Carmo Gouveia ^a  

^a FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Butyrates; Colonic neoplasms; Precancerous conditions; Rats

Indexed keywords

1,2 DIMETHYLHYDRAZINE; ACETIC ACID; BUTYRIC ACID; HISTAMINE; PROPIONIC ACID; PUTRESCINE; SHORT CHAIN FATTY ACID; SPERMIDINE; SPERMINE; WATER;

ABERRANT CRYPT FOCUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DISEASE COURSE; FECES; FECES LEVEL; LARGE INTESTINE; LIPID ANALYSIS; MALE; NONHUMAN; PRECANCER; RAT;

1,2-DIMETHYLHYDRAZINE; ABERRANT CRYPT FOCI; ANIMALS; BUTYRATES; CARCINOGENS; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; FATTY ACIDS; FECES; INTESTINE, LARGE; MALE; POLYAMINES; PRECANCEROUS CONDITIONS; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 78650580929     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/S0102-86502010000600009     Document Type: Article

References (25)

1. Jullumstrø E, Lydersen S, Møller B, Dahl O, Edna TH. Duration of symptoms, stage at diagnosis and relative survival in colon and rectal cancer. Eur J Cancer. 2009;45(13):2383-90.
2. Stevens RG, Swede H, Rosenberg DW. Epidemiology of colonic aberrant crypt foci: review and analysis of existing studies. Cancer Lett. 2007;252:171-83.
3. Larqué E, Sabater-Molina M, Zamora S. Biological significance of dietary polyamines. Nutrition. 2007;23(1):87-95.
4. Gerner EW, Meyskens FL Jr. Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer. 2004;4(10):781-92.
5. Brouns F. Kettlitz B, Arrigoni E. Resistant starch and "the butyrate revolution". Trends Food Sci Tech. 2002;23:251-61.
6. Rose DJ, DeMeo MT, Keshavarzian A, Hamaker BR. Influence of dietary fiber on inflammatory bowel disease and colon cancer: importance of fermentation pattern. Nutr Rev. 2007;65(2):51-62.
7. Slavin J L. Whole grain and human health. Nutr Res Rev. 2004;17:99-110.
8. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth MJ, Kinghorn I, Fraser NJ, Pike NB, Strum JC, Steplewski KM, Murdock PR, Holder JC, Marshall FH, Szekeres PG, Wilson S, Ignar DM, Foord SM, Wise A, Dowell SJ. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem. 2003;28;278(13):11312-9.
9. Gupta N, Martin P M, Prasad PD, Ganapathy V. SLC5A8 (SMCT1)-mediated transport of butyrate forms the basis for the tumor suppressive function of the transporter. Life Sci. 2006;18;78(21):2419-25.
10. Tong X, Yin L, Giardina C. Butyrate suppresses Cox-2 activation in colon cancer cells through HDAC inhibition. Biochem Biophys Res Commun. 2004;317:463-71.
11. Zgouras D, Wachtershauser A, Frings D, Stein J. Butyrate impairs intestinal tumor cell-induced angiogenesis by inhibiting HIF-1α nuclear translocation. Biochem Biophys Res Commun. 2003;300(4):832-8.
12. waf1 transcription in human cells. J Biol Chem. 2000;30725-33.
13. Reeves P G, Nielsen FH, Junior GCF. AIN-93 purified diets for laboratory rodents: final report of the american institute of nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993;123:1939-51.
14. Freeman HJ. Effects of differing concentrations of sodium butyrate on 1,2-dimethylhydrazine-induced rat intestinal neoplasia. Gastroenterology. 1986;91(3):596-602.
15. Rodrigues MAM, Silva LAG, Salvador DMF, Camargo JLV, Montenegro MR. Aberrant crypt foci and colon cancer: comparison between a short- and medium-term biossay for colon carcinogenesis using dimethylhidrazine in Wistar rat. Braz J Med Biol Res. 2002;35:351-5.
16. Bird RP. Observations and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 1987;37:147-51.
17. Vale SR, Glória MB. Determination of biogenic amines in cheese. J AOAC Int. 1997;80(5):1006-12.
18. Smirick-Tjardes MR, Grieshop CM, Flickinger EA, Bauer LL, Fahey GCJr. Dietary galactooligosaccharides affect ileal and total-tract nutrient digestibility, ileal and fecal bacterial concentrations, and ileal fermentive characteristics of growing pigs. J Anim Sci. 2003;81:2535-45.
19. Liu R, Xu G. Effects of resistant starch on colonic preneoplastic aberrant crypt foci in rats. Food Chem Toxicol. 2008;46(8):2672-9.
20. Raju J, Swamy MV, Cooma I, Patlolla JM, Pittman B, Reddy BS, Steele VE, Rao CV. Low doses of beta-carotene and lutein inhibit AOM-induced rat colonic ACF formation but high doses augment ACF incidence. Int J Cancer. 2005;113(5):798-802.
21. Scharlau D, Borowicki A, Habermann N, Hofmann T, Klenow S, Miene C, Munjal U, Stein K, Glei M. Mechanisms of primary cancer prevention by butyrate and other products formed during gut-flora mediated fermentation of dietary fibre. Mutat Res. 2009;682(1):39-53
22. Kanna PS, Mahendrakumar CB, Chakraborty T, Hemalatha P, Banerjee P, Chatterjee M. Effect of vanadium on colonic aberrant crypt foci induced in rats by 1,2 Dimethyl hydrazine. World J Gastroenterol. 2003;9(5):1020-7.
23. Wallace H M, Niiranen K. Polyamine analogues - an update. Amino Acids. 2007;33(2):261-5.
24. Wallace HM, Caslake R. Polyamines and colon cancer. Eur J Gastroenterol Hepatol. 2001;13:1033-9.
25. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 1997;275(5297):218-20.